期刊文献+

神经生长因子和氨基胍对糖尿病大鼠视觉诱发电位的影响

Influence of nerve growth factor and aminogunidine on visual evoked potential in diabetic rats
下载PDF
导出
摘要 目的:观测糖尿病大鼠视觉诱发电位(VEP)的改变以及神经生长因子(NGF)和氨基胍(AG)对其的影响。方法:用链脲佐菌素(STZ)制作糖尿病大鼠动物模型,分为正常对照组(CON组)、糖尿病对照组(DM组)、糖尿病NGF治疗组(D+N组)、糖尿病AG治疗组(D+A组)。分别于病程3、6、9、12个月进行各组大鼠的VEP测定。结果:与CON组相比,其他各组大鼠在各实验时点的VEP潜伏期延长、波幅下降(P<0.01);6个月及9个月时,D+N组及D+A组的潜伏期均较DM组缩短,且差异显著(P<0.05).而波幅仅见6个月时部分回升;12个月时,除D+A组波幅较DM组略有回升外,其余改变与9个月时类似。结论:NGF和AG能够改善DM导致的大鼠VEP潜伏期延长及波幅下降。 Objective:To observe the changes of visual evoked potential (VEP) in diabetic rats and the influence of nerve growth factor (NGF) and aminoguanidine (AG) on VEP. Methods: Diabetes was induced in adult male Wistar rats with streptozotocin (STZ). Rats were divided into normal control group (CON),diabetes model group (DM), NGF-treated group (D+N) and AG-treated group(D+ A). VEP was measured during the 3rd month, 6^th month, 9^th month,and 12^th month. Results: Compared with the CON group,all rest groups had longer latencies and lower amplitudes (P〈0. 01). During the 6^th and 9^th months, the latencies in group D+N and group D+A were significantly decreased (P〈0.05) compared with DM group, and the amplitude was partially recoved during the 6^th month. The changes during the 12^th month were similar to those of the 9^th month, except that the amplitude in D+A group was slightly higher than that in the DM group. Conclusion: NGF and AG can improve DM-induced elongation of VEP latency and decrease of VEP amplitude.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2008年第6期655-658,共4页 Academic Journal of Second Military Medical University
关键词 糖尿病 视觉诱发电位 神经生长因子 氨基胍 diabetes mellitus visual evoked potential nerve growth factor aminoguanidine
  • 相关文献

参考文献17

  • 1Brown A F,Jiang L,Fong D S,Gutierrez P R,Coleman A L, Lee P P,et al. Need for eye care among older adults with diabetes mellitus in fee-for-service and managed medieare[J]. Arch Opht halmol, 2005,123 : 669-675
  • 2Varma R, Torres M, Pena F, Klein R, Azen S P, Los Angeles Latino Eye Study Group. Prevalence of diabetic retinopathy in adult Latinos the Los Angeles Latino eye study[J]. Ophthalmology, 2004,111 : 1298-1306.
  • 3Kempen J H,O'Colmain B J,Leske M C,Haffner S M, Klein R,Moss S E, et al. The prevalence of diabetic retinopathy among adults in the United States[J].Arch Ophthalmol, 2004, 122:552-563.
  • 4I.i Q,Zemel E,Miller B,Perlman I. Early retinal damage in experimental diabetes: electroretinographical and morphological observations[J]. Exp Eye Res,2003,77:115-116.
  • 5Baber A J. A new view of diabetic retinopathy:a neurodegenerative disease of the eye[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2003,27 : 283-290.
  • 6崔彦,许迅.糖尿病性视网膜病变分子机制的研究进展[J].眼视光学杂志,2007,9(2):135-138. 被引量:6
  • 7Phipps J A, Fletcher E L, Vingrys A J. Paried-flash identification of rod and cone dysfunction in the diabetic rat[J]. Invest Ophthalmol Vis Sci, 2004,45 : 4592-4600.
  • 8Sugimoto M,Sasoh M,Ido M,Wakitani Y,Takahashi C,Uji Y. Detection of early diabetic change with optical coherence tomography in type 2 diabetes mellitus patients without retinopathy[J]. Opht halmologica, 2005,219 : 379-385.
  • 9潘映福.临床诱发电位学[M].北京:人民卫生出版社,1988.245-72.
  • 10Dyck P J ,Giannini C. Pathologic alterations in the diabetic neuropathies of humans[J].J Neuropathol Exp Neurol,1996,55: 1181-1193.

二级参考文献28

  • 1Xia P,Kramer RM,King GL.Identification of the mechanism for the inhibition of Na,K-adenosine triphosphatase by hyperglycemia involving activation of protein kinase Cand cytosolic phospholipase A2[J].J Clin Invest,1995,96(5):733-740.
  • 2Williamson JR.Hyperglycemic pseudohypoxia and diabetic complications[J].Diabetes,1993,42(4):801-813.
  • 3Engerman RL,Kem TS,Larson ME.Nerve conduction and aldose reductase inhibition during 5 years of diabetes or galactosaemia in dogs[J].Diabetologia,199,37(2):141-144.
  • 4Greene DA,Arezzo JC,Brown MB.Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy.Zenarestat Study Group[J].Neurology,1999,53(4):580-591.
  • 5Stitt AW.Advanced glycation end products (AGEs) co-localize with AGE reoeptors in the retinal vasculature of diabetic and of AGE-infused rats[J].Am J Pathol,1997,150(4):523-528.
  • 6Degenhardt TP,Thorpe SR,Baynes JW,Chemical modification of proteins by methylglyoxal[J].Cell Mol Biol,1998,44(11):1139 -1145.
  • 7Hammes HP.Aminoguanidine treatment inhibits the development of experimental diabetic retinopath[J].Proc Natl Acad Sci,1991,88(12):11555-11559.
  • 8Yan SD.Enhanced cellular oxidant stress by the interaction od advanced glycation end products with their receptors/binding Proteins[J].J Biol Chem,1994,269(11):9889-9897.
  • 9Lander HM.Activation of the receptor for advanced glycation end products triggers a p21 (ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress[J].J Biol Chem,1997,272(12):17810-17814.
  • 10Yamagishi S.Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvasular endothelial cells[J].Diabetologia,1998,41(12):1435-1441.

共引文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部